EUVIMEDEUVIMED entdecken
Crossref

Abstract 4875: Addition of K ATP Channel Opener Diazoxide to del Nido Cardioplegia in a Mouse Langendorff Model

AlleaBelle Bradshaw, Caroline Tran, Jace Bradshaw, Christopher Rumer, Michelle Carvajal, Shivani Shirodkar, Jennifer S Lawton

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.4875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von AlleaBelle Bradshaw und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Myocardial stunning affects 12-65% of patients undergoing cardiac surgery and is associated with worse outcomes. Diazoxide (DZX), an ATP-sensitive potassium (K ATP ) channel opener, mimics ischemic preconditioning and reduces stunning in multiple animal models when added to St. Thomas (ST) cardioplegia. In 2025, an FDA-approved Phase 1 trial was completed in humans with DZX added to ST cardioplegia. However, DZX has not been evaluated as an additive to other commonly utilized cardioplegia solutions, which is a barrier to widespread clinical adoption. Our primary objective was to demonstrate myocardial protection by DZX when added to del Nido (dN) cardioplegia. Our secondary objective was to compare cardiac recovery with dN alone vs ST alone in this model. We hypothesized that dN with DZX would be superior to dN and that ST would be superior to dN.

Methods

Mouse hearts underwent Langendorff perfusion for 30 min, baseline data collection, cardioplegia delivery (dN, dN+DZX, or ST, n=9 each), 90 min of global ischemia, and 30 min reperfusion and data collection. A left ventricular (LV) balloon measured LV developed pressure (LVDP) and end diastolic pressure (EDP). LVDP and EDP were compared before and after global ischemia at identical balloon volumes. Percent change from baseline in EDP and LVDP was compared between groups using t-tests.

Results

Hearts with poor contractile recovery were excluded from analysis based on a priori interquartile range criteria (n=2 in dN, n=2 in dN+DZX, and n=2 in ST). There were no significant differences in baseline coronary flow, EDP, or LVDP between groups. LVDP decreased and EDP increased after ischemia in all groups. Comparing dN to dN+DZX, there were no differences in EDP, however, there was a statistically significant improvement in LVDP only in the 2.8 μL volume (p=0.037) ( Figure ). When comparing dN to ST alone, there were no differences in post ischemic EDP or LVDP.

Conclusions

We have demonstrated in multiple animal models that DZX added to hypothermic, hyperkalemic St. Thomas cardioplegia provides improved myocardial protection. In the present study, DZX in del Nido cardioplegia provided improvement in LVDP (only in one balloon volume) but not in EDP. Further investigation of the use of K ATP channel openers in del Nido cardioplegia is needed as the lidocaine in del Nido may inhibit ischemic preconditioning due to its known inhibition of K ATP channels.

Zitieren

APA

Bradshaw, A., Tran, C., Bradshaw, J., Rumer, C., Carvajal, M., Shirodkar, S., & Lawton, J. S. (2026). Abstract 4875: Addition of K ATP Channel Opener Diazoxide to del Nido Cardioplegia in a Mouse Langendorff Model. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.4875

Vancouver

Bradshaw A, Tran C, Bradshaw J, Rumer C, Carvajal M, Shirodkar S, et al. Abstract 4875: Addition of K ATP Channel Opener Diazoxide to del Nido Cardioplegia in a Mouse Langendorff Model. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.4875

BibTeX
@article{Bradshaw2026,
  author = {Bradshaw, AlleaBelle and Tran, Caroline and Bradshaw, Jace and Rumer, Christopher and Carvajal, Michelle and Shirodkar, Shivani and Lawton, Jennifer S},
  title = {Abstract 4875: Addition of K ATP Channel Opener Diazoxide to del Nido Cardioplegia in a Mouse Langendorff Model},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.4875}
}
Kostenlos starten →